Pathological evaluation of neoadjuvant chemotherapy in advanced gastric cancer.

Shen-Bao HuChun-Hao LiuXiang WangYun-Wei DongLin ZhaoHong-Feng LiuYue CaoDing-Rong ZhongWei LiuYan-Long LiWei-Sheng GaoChun-Mei BaiZhong-Hua ShangXiao-Yi Li

Published in: World journal of surgical oncology (2019)

The Lauren classification and ypTNM stage after neoadjuvant chemotherapy are independent prognostic factors in advanced gastric cancer. A GHR ≥ 50%/< 50% can be used as the primary criterion for advanced gastric cancer after neoadjuvant chemotherapy to determine postoperative adjuvant chemotherapy regimens.

Keyphrases

neoadjuvant chemotherapy
prognostic factors
locally advanced
lymph node
sentinel lymph node
machine learning
patients undergoing
rectal cancer